Cargando…

Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a highly heterogeneous disease, with more than 40% of patients initially diagnosed with multinodular HCCs. Although circulating cell-free DNA (cfDNA) has been shown to effectively detect somatic mutations, little is known about its utility to capture intratumor hete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coto-Llerena, Mairene, Benjak, Andrej, Gallon, John, Meier, Marie-Anne, Boldanova, Tuyana, Terracciano, Luigi M., Ng, Charlotte K.Y., Piscuoglio, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926063/ https://www.ncbi.nlm.nih.gov/pubmed/35263170 http://dx.doi.org/10.1200/PO.21.00335

Ejemplares similares

Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages
por: Ng, Charlotte K. Y., et al.
Publicado: (2022)

Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization
por: Boldanova, Tuyana, et al.
Publicado: (2021)

Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report
por: Ercan, Caner, et al.
Publicado: (2022)

Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors
por: Blumer, Tanja, et al.
Publicado: (2019)

The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective
por: Zanotti, Sofia, et al.
Publicado: (2022)

Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
por: Meier, Marie-Anne, et al.
Publicado: (2022)

Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens
por: Srivatsa, Sumana, et al.
Publicado: (2022)

Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma
por: Gallon, John, et al.
Publicado: (2021)

Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity
por: Shi, Weiwei, et al.
Publicado: (2018)

Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis
por: Taha-Mehlitz, Stephanie, et al.
Publicado: (2021)

High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes
por: Coto-Llerena, Mairene, et al.
Publicado: (2020)

Breast cancer intra-tumor heterogeneity
por: Martelotto, Luciano G, et al.
Publicado: (2014)

Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook
por: Ng, Charlotte K. Y., et al.
Publicado: (2018)

Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo‐Independent Regulation of Heat Shock Protein 70 Family Members
por: Coto‐Llerena, Mairene, et al.
Publicado: (2021)

Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens
por: Montazeri, Hesam, et al.
Publicado: (2021)

Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
por: Nuciforo, Sandro, et al.
Publicado: (2018)

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
por: Gao, Ruize, et al.
Publicado: (2021)

Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues
por: Marinucci, Mattia, et al.
Publicado: (2022)

Small crystals with severe consequences
por: Klasen, Jennifer M, et al.
Publicado: (2021)

Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis
por: Simó-Riudalbas, Laia, et al.
Publicado: (2022)

Arginine reprograms metabolism in liver cancer via RBM39
por: Mossmann, Dirk, et al.
Publicado: (2023)

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
por: Bianco, Gaia, et al.
Publicado: (2022)

Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
por: Bianco, Gaia, et al.
Publicado: (2022)

Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses
por: Kim, Soon‐Chan, et al.
Publicado: (2021)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model
por: Suter, Polina, et al.
Publicado: (2022)

Massive multinodular goiter with stridor
por: Kumar, K.V.S. Hari, et al.
Publicado: (2012)

Multinodular and Vacuolating Neuronal Tumor
por: Zahra, Charmaine, et al.
Publicado: (2018)

Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer
por: Garioni, Michele, et al.
Publicado: (2023)

The Role of Long Non-Coding RNAs in Hepatocarcinogenesis
por: Lanzafame, Manuela, et al.
Publicado: (2018)

USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis
por: Gao, Ruize, et al.
Publicado: (2021)

The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples
por: Stücheli, Simon, et al.
Publicado: (2022)

Evolutionary Dynamics of Intratumor Heterogeneity
por: Iwasa, Yoh, et al.
Publicado: (2011)

Targeting the intratumor heterogeneity in PMBL
por: Ritz, Olga, et al.
Publicado: (2014)

Intratumor and Intertumor Heterogeneity in Melanoma
por: Grzywa, Tomasz M., et al.
Publicado: (2017)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Intratumoral Heterogeneity in Lung Cancer
por: Lv, Xiaodi, et al.
Publicado: (2023)

Interferon lambda 4 can directly activate human CD19(+) B cells and CD8(+) T cells
por: Coto-Llerena, Mairene, et al.
Publicado: (2020)

Patient outcomes following surgical management of multinodular goiter: Does multinodularity increase the risk of thyroid malignancy?
por: Lin, Yann-Sheng, et al.
Publicado: (2016)

Congenital thyroid hemiagenesis with multinodular goiter
por: Bhartiya, SK, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lnnmtt217u1jncqg0fcurnmng7